• 1
    Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
  • 2
    Lipton RB, Diamond S, Diamond M, et al. Prevalence and sociodemographics of migraine headache in the United States 1999: Data from the American Migraine Study II. Submitted.
  • 3
    Von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology. 1998;50:1741-1745.
  • 4
    Dahlöf CG & Solomon GD. The burden of migraine to the individual sufferer: a review. Eur J Neurol. 1998;5:525-533.
  • 5
    Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: a population-based case-control study. Neurology. 2000;55:629-635.
  • 6
    Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000;55:624-629.
  • 7
    Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813-818.
  • 8
    Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache. 1998;38:87-96.
  • 9
    Lipton RB & Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology. 1993;43(suppl 3):S6-S10.
  • 10
    Lipton RB, Stewart WF, Von Korff M. The burden of migraine. A review of cost to society. Pharmacoeconomics. 1994;6:215-221.
  • 11
    Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample survey. Headache. 1992;32:223-228.
  • 12
    Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med. 1992;152:1273-1278.
  • 13
    Silberstein SD & Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology. 2000;54:1553.
  • 14
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
  • 15
    Lipton RB, Scher DI, Kolodner K, et al. Migraine in the United States: Epidemiology and patterns of health care use. Submitted.
  • 16
    Lipton RB, Goadsby PJ, Sawyer JP, et al. Migraine: diagnosis and assessment of disability. Rev Contemp Pharmacother. 2000;11:63-67.
  • 17
    Blau JN & MacGregor EA. Migraine consultations: a triangle of viewpoints. Headache. 1995;35:104-106.
  • 18
    MacGregor EA. The doctor and the migraine patient: improving compliance. Neurology. 1997;48(suppl 3):S16-S20.
  • 19
    Carr-Hill R, Jenkins-Clarke S, Dixon P, et al. Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy. 1998;3:207-213.
  • 20
    Rasmussen BK. Epidemiology of headache. Cephalalgia. 1995;15:45-68.
  • 21
    Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-762.
  • 22
    Stewart WF, Simon D, Schechter A, Lipton RB. Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol. 1995;48:269-280.